Cargando…
Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells
IL-27, a member of the IL-12-family of cytokines, has shown anti-tumor activity in several pre-clinical models due to anti-proliferative, anti-angiogenic and immune-enhancing effects. On the other hand, IL-27 demonstrated immune regulatory activities and inhibition of auto-immunity in mouse models....
Autores principales: | Petretto, Andrea, Carbotti, Grazia, Inglese, Elvira, Lavarello, Chiara, Pistillo, Maria Pia, Rigo, Valentina, Croce, Michela, Longo, Luca, Martini, Stefania, Vacca, Paola, Ferrini, Silvano, Fabbi, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341926/ https://www.ncbi.nlm.nih.gov/pubmed/27683036 http://dx.doi.org/10.18632/oncotarget.12235 |
Ejemplares similares
-
IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells
por: Carbotti, Grazia, et al.
Publicado: (2017) -
Dual Roles of IL-27 in Cancer Biology and Immunotherapy
por: Fabbi, Marina, et al.
Publicado: (2017) -
IL-27 Mediates PD-L1 Expression and Release by Human Mesothelioma Cells
por: Carbotti, Grazia, et al.
Publicado: (2021) -
IL-27 induces the expression of IDO and PD-L1 in human cancer cells
por: Carbotti, Grazia, et al.
Publicado: (2015) -
Cytokine-Induced Guanylate Binding Protein 1 (GBP1) Release from Human Ovarian Cancer Cells
por: Carbotti, Grazia, et al.
Publicado: (2020)